{"name":"Institut National de la Santé Et de la Recherche Médicale, France","slug":"institut-national-de-la-sant-et-de-la-recherche-m-dicale-france","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"cardiovascular","drugs":[{"name":"Bilhvax vaccine (Sh28GST)","genericName":"Bilhvax vaccine (Sh28GST)","slug":"bilhvax-vaccine-sh28gst","indication":"Schistosomiasis haematobium (urogenital schistosomiasis)","status":"phase_3"},{"name":"Tahor","genericName":"Tahor","slug":"tahor","indication":"Other","status":"phase_2"},{"name":"Xenbilox","genericName":"Xenbilox","slug":"xenbilox","indication":"Other","status":"phase_2"},{"name":"curcuma longa","genericName":"curcuma longa","slug":"curcuma-longa","indication":"Other","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Rapamycin","genericName":"Rapamycin","slug":"rapamycin","indication":"Gorham's disease","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Anti-H1N1v Vaccine","genericName":"Anti-H1N1v Vaccine","slug":"anti-h1n1v-vaccine","indication":"Prevention of H1N1 influenza infection","status":"marketed"}]}],"pipeline":[{"name":"Rapamycin","genericName":"Rapamycin","slug":"rapamycin","phase":"marketed","mechanism":"Peptidyl-prolyl cis-trans isomerase FKBP3, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2","indications":["Gorham's disease","Lymphangiectasis","Lymphangioma","Lymphangiomatosis","Prevention of Kidney Transplant Rejection"],"catalyst":""},{"name":"Anti-H1N1v Vaccine","genericName":"Anti-H1N1v Vaccine","slug":"anti-h1n1v-vaccine","phase":"marketed","mechanism":"This vaccine stimulates the immune system to produce antibodies and cellular immunity against the H1N1 influenza virus.","indications":["Prevention of H1N1 influenza infection"],"catalyst":""},{"name":"Bilhvax vaccine (Sh28GST)","genericName":"Bilhvax vaccine (Sh28GST)","slug":"bilhvax-vaccine-sh28gst","phase":"phase_3","mechanism":"Bilhvax is a recombinant vaccine targeting schistosome antigens to induce immune responses against Schistosoma haematobium infection.","indications":["Schistosomiasis haematobium (urogenital schistosomiasis)"],"catalyst":""},{"name":"Tahor","genericName":"Tahor","slug":"tahor","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Xenbilox","genericName":"Xenbilox","slug":"xenbilox","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"curcuma longa","genericName":"curcuma longa","slug":"curcuma-longa","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQWGZHRzZMcW5yMl91RjlDTVZfbXNkVU9LaURIRG9BdjN6aG14SXdZTm56UjAtcUVKU1Z6NTYwcS1ER2tzbV9OVld2bmVwaW95aDVTNmlIUHpTYlFzZ29KSlRBT0hsR1pMajhBeXZfNkdTb2ZqSHhIcHJFSUs4eE5wM3ZQVG5GMEZI?oc=5","date":"2025-11-24","type":"pipeline","source":"presse.inserm.fr","summary":"Prix Inserm 2025 : l’innovation au cœur de la santé - presse.inserm.fr","headline":"Prix Inserm 2025 : l’innovation au cœur de la santé","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1PazlMUzV6bThDNlUyTl9pQ1BoUWt0OVpYQU9PMnk2M2duamJGSHQyZ2tKRzlRMm1jeFNPRWJPVXFtSm4tNGpWbDluRWlsWWhFSkV0bkowQkxSeU5RYzNR?oc=5","date":"2024-11-27","type":"pipeline","source":"nature.com","summary":"Decoding meditation mechanisms underlying brain preservation and psycho-affective health in older expert meditators and older meditation-naive participants - nature.com","headline":"Decoding meditation mechanisms underlying brain preservation and psycho-affective health in older expert meditators and ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE01N01BZjhUVTJEandNeVBrT3pSVnJJTWRRc0RBRF9ETFg3N2NDeHlxbEpRc01rdkV3UVVFRDE1Y2piTVUyajFJMlFhVUgtVjU5U1JScEJmcUxnb0VCSnk0?oc=5","date":"2024-06-26","type":"pipeline","source":"nature.com","summary":"Differences between subjective and disability health expectancies across ages in older adults - nature.com","headline":"Differences between subjective and disability health expectancies across ages in older adults","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPOV92WUNzek9BWjJIalZiTGxsblVnSm9EZ3BMZE8weDBBa2ZMZGFRbUFnV1h4U2FUUklaMDFpZVpGemtzaWdBUm5TUHJGZ0dfbkZqMGdnTk1rM2RNYVdBelY1c21rUkhSTnVlakNvLW9uOEZ1R2hCU29PamFrMVNsODFVWjdtbjd3TVZmRmFfcFdlcmhsSUE?oc=5","date":"2024-06-25","type":"pipeline","source":"Frontiers","summary":"Overcoming Market Failures in Pandemic Drug Discovery Through Open Science: A Canadian Solution - Frontiers","headline":"Overcoming Market Failures in Pandemic Drug Discovery Through Open Science: A Canadian Solution","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNeVFYVF8zWDFMcjF4MGRWOUF6YXFCSUtCQUJlc2VGXzFiRTBqVnBhaF96ZlM5SlJyNU82bXhXQzBzZHRWM2JCZjc2V2pCeFl2SFV2aDNzZ0JOYTNXeklZeFFURTM2WXotMUJLM3l0a2hJNU1LaHYwb3RhSjQ5Q01fd3ExdmlhSUdFSlBHcFZKSQ?oc=5","date":"2024-02-05","type":"pipeline","source":"Frontiers","summary":"Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma - Frontiers","headline":"Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxONWhWY0twTTNZU2dQc1VKSExCSVRDb2VMQWlQenpCSkM2MTR6XzJ5a09KYllDeG5Yd1BtSmN1V01vVUpCUU1MQkpPdnQySDl0T1pMZk8yQ2VzSFNRLWdOSTFWNGQzek5CX0NWQUNBZjNwU2tEZm1sRE1LaWdoWllMdUxtUld4eVpvSW9FczlMX1U3YTVsX3dR?oc=5","date":"2024-01-30","type":"pipeline","source":"Frontiers","summary":"The case of the missing mouse—developing cystic fibrosis drugs without using animals - Frontiers","headline":"The case of the missing mouse—developing cystic fibrosis drugs without using animals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNNWstVlJSSlh5anREUVc2NUFLcmQ4el9OMHc1Qy0xblU3bU40T29nSFNuSUQ0S2ltNjJOTlRCc2hGdTk5dEM1VGxlay1LTVNBVzFrZlZUVmZLVUxZQlpHVGotVFhfVjZrckUxMnZBNHRqRmxNUTJFZHByLWdKRjkzbHlKbVA4dlpCTlkyVHVZN0N5ZDNiNGw5dHlqcEpwUzlKSWFNVTNaVnNGa20wbEdPMC1ZWXNDZkVRZERxaU9zeHRNdGRIMGhv?oc=5","date":"2023-11-09","type":"pipeline","source":"respiratory-therapy.com","summary":"Prenatal Exposure to Cadmium Linked to Child Asthma, Allergies - respiratory-therapy.com","headline":"Prenatal Exposure to Cadmium Linked to Child Asthma, Allergies - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPX3FVRjBZeHlsMlhmeTBwVVh2T0xxaHZINEdvaFRRQUs3Yld5a2ZuSnIxY0tsZTNoeDVMRGpHLV9tYVhOTGxZV05OTlZBbU9HX01ROFVUeEFEU01DLUtrb2FFMWxJOVZvSE9XUGxaNjUycHFwOVlGQk5zN3o0elVzdVVWc0g4Mm9mWW8xbzdoaGx2bzN1cGNVT20wUS1BMUxsMXFtUWpWQURrdw?oc=5","date":"2022-09-06","type":"pipeline","source":"Rockefeller University Press","summary":"Bringing natural killer cells to the clinic - Rockefeller University Press","headline":"Bringing natural killer cells to the clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE1ER3RYVXJ5M3pvSVNaQXFibUpQQWhPWjlQZFRkRnZJUlZOS1ZQakEyNHBEUkYwb3U0ZkQ1SWpOdk5UQ3Fnd01aVDhNNGdTc1FJUUtkM1NsNC1WS0E5?oc=5","date":"2022-03-03","type":"pipeline","source":"PNAS","summary":"Recognition of peptide–MHC class I complexes by activating killer immunoglobulin-like receptors - PNAS","headline":"Recognition of peptide–MHC class I complexes by activating killer immunoglobulin-like receptors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNOF9SbHdNSlkwT1ZzZEtBc2QtMjFkWWNwOWtJNXJUQzA4Qkwzamk2R25JTkFDNE9WREdGbmh2bnRhb3lFaURfaFVTX2JUTmFlSnA1aVRUY2FzU0lMdUhKMzFiOEdIZEZkb1Y1UW1ULVJyMDdkOHJObWxrX0gxcXdmTUFwcTBES0JHczNaQ0M5N25ycEwtTFN3WUlMcUNuNUVn?oc=5","date":"2022-01-26","type":"pipeline","source":"Rockefeller University Press","summary":"Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib | Journal of Experimental Medicine - Rockefeller University Press","headline":"Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib | Journal of Experimental Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9IdEZGbVZPNi12aXgwVUI1NDJ4VS0yOEI1WVFKdjZjaGM2LXBNc0ZSNGFGYjNGaV9IRXE1QTNTSE9KcDgzbUs3am1ScDlfQUw2Q1c0dUF4aFllclY4cTZB?oc=5","date":"2021-07-06","type":"pipeline","source":"nature.com","summary":"Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis - nature.com","headline":"Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOakJ4YTFFWGNjeERlT1o2VXJtQjJrWl9kTDUtLTRaYUhqODI4UDlZVUlzWnlXZDNKUHJCQ2tzaEpoRjhkdTNkMUl6NWVwNzZRRVh5N0xrS0R4VFkza2hNNmpFLU00SnpXYVYxblZnNEU4QmV1NloyaW1Xc1J4T0YxOVNicUZiTnhZUjJEUVZJRFhLNHY0WGdlbjZ1bF8wQVd6b1hIYmpMdw?oc=5","date":"2019-12-06","type":"pipeline","source":"Rockefeller University Press","summary":"Effects of interleukin-2 in immunostimulation and immunosuppression - Rockefeller University Press","headline":"Effects of interleukin-2 in immunostimulation and immunosuppression","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"marketed":3,"phase_3":1,"phase_2":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}